Predicting short-term outcome in severely ill heart failure patients: implications regarding listing for urgent cardiac transplantation and patient selection for temporary ventricular assist device support.

[1]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[2]  G. MacGowan,et al.  Circulating interleukin-6 in severe heart failure. , 1997, The American journal of cardiology.

[3]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[4]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[5]  H. Oral,et al.  Tumor necrosis factor‐α and the failing human heart–TNFα and heart failure , 1995 .

[6]  M. Mathier,et al.  Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. , 1995, Journal of the American College of Cardiology.

[7]  D. Mann,et al.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.

[8]  R. Hetzer,et al.  Interleukin‐6 and interleukin‐8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation , 1994, Critical care medicine.

[9]  G. Fonarow,et al.  The impending crisis awaiting cardiac transplantation. Modeling a solution based on selection. , 1994, Circulation.

[10]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[11]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[12]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[13]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[14]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[15]  P. Reddy,et al.  Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. , 1990, The Journal of clinical endocrinology and metabolism.

[16]  U. Gullberg,et al.  Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. , 1986, The Journal of clinical investigation.

[17]  M. Packer,et al.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.

[18]  L. Horowitz,et al.  Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.

[19]  J. Cohn,et al.  Increased plasma arginine vasopressin levels in patients with congestive heart failure. , 1983, Journal of the American College of Cardiology.

[20]  D. Ganten,et al.  Plasma angiotensin II concentrations and experimentally induced thirst. , 1981, The American journal of physiology.

[21]  N. Hollenberg,et al.  Relation of the Renin‐Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure , 1981, Circulation.

[22]  P. Kissinger,et al.  Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatography. , 1981, Analytical chemistry.

[23]  E. Espiner,et al.  Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. , 1980, Clinical science.

[24]  J. O. Davis.  The control of renin release. , 1973, The American journal of medicine.

[25]  E. Haber,et al.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. , 1969, The Journal of clinical endocrinology and metabolism.